Atheromatous renovascular disease (ARVD) is a common and challenging disease. It is increasingly associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), hypertension and cardiovascular burden. Controversy exists regarding the safest investigative methods as well as optimum treatment of this condition. In this review, we provide an overview of ARVD and discuss the challenges still remaining. © 2008 European Dialysis and Transplant Nurses Association/European Renal Care Association.
- Angioplasty and stent for renal arterial lesions (ASTRAL)
- Angiotensin converting enzyme-inhibitors (ACE-I)
- Angiotensin receptor blockers (ARB)
- Atheromatous renovascular disease